Description
Faviparivir is a pyrazinecarboxamide-derivative antiviral medication originally from Japan and used to treat influenza. Its usage has since been expanded to treat other viral infections, and it works by preventing viruses from being able to copy their genetic material. This duplication process is essential for the virus’ spread and ability to generate symptoms and adversely affect the health of those afflicted with it. Faviparivir works by impeding RNA-polymerase activity within affected cells.
Medical Use
Treatment of Influenza A and B viruses has been the primary application for Faviparivir to date. While it is also used to treat Ebola virus, Yellow fever, and Nipah virus too, these 3 treatments are still under trial. At this time it is also being evaluated as a potential treatment for COVID-19 (coronavirus) but such a usage still hasn’t been approved in the USA or elsewhere. Among other aspects, it is particularly highly touted for an absorption rate of nearly 98%.
Side Effects
Patients may experience any of the following side effects after taking Faviparivir:
- Vomiting
- Reduced body weight
- General side effects resulting from decreased production of red blood cells, increased liver function
- Reduced locomotive activity
Plus, it is important to know that Favipiravir may cause congenital defects and pregnant women should NOT use Favipiravir at any time during their pregnancy.
Brand Names
Favipiravir is sold under the brand name Avigan, and the US FDA for emergency use as a potential COVID-19 treatment in May of 2020.
IMPORTANT NOTE:
The above information is intended to increase awareness of health information and does not suggest treatment or diagnosis. This information is not a substitute for individual medical attention and should not be construed to indicate that use of the drug is safe, appropriate, or effective for you. See your health care professional for medical advice and treatment.
Product Code : 13380